Bioscience
AGC Biologics appoints David Stewart as new GM/site head in Boulder
BOULDER -- AGC Biologics announced a new appointment to oversee the startup, strategic development and operational excellence in large-scale biologics production at itsBoulder site. ... Read More
Friday January 22, 2021 0 comments
InDevR launches VaxArray Measles and Rubella Kit for improved vaccine antigen characterization
BOULDER -- InDevR, Inc. announced commercial availability of its VaxArray Measles and Rubella (MR) antigen quantification kit. Funded by the Bill and Melinda Gates Foundation with the goal of... Read More
Tuesday January 19, 2021 0 comments
Zynex announces filing of patent for sepsis monitor
ENGLEWOOD -- Zynex, Inc. (NASDAQ: ZYXI), announced it has filed for a provisional patent for a noninvasive sepsis monitor. "Sepsis is one of the biggest problems in hospitals today,” said ... Read More
Friday January 15, 2021 0 comments
Biodesix and HiberCell collaborate for companion diagnostic discovery, development and commercialization
BOULDER NEW YORK -- Biodesix, Inc. (Nasdaq: BDSX) today announced an agreement with HiberCell , a biotechnology company developing novel therapeutics for cancer relapse and metastasis, to further... Read More
Friday January 15, 2021 0 comments
BioIntelliSense and American College of Cardiology join to advance remote cardiac care
DENVER -- BioIntelliSense, Inc. announced the company has formed a strategic collaboration with the American College of Cardiology (ACC) that combines innovative medical-grade wearable devices and... Read More
Tuesday January 12, 2021 0 comments
Zynex announces second utility patent for its blood volume monitor
ENGLEWOOD -- Zynex, Inc . (NASDAQ: ZYXI) reported it has obtained a second U.S. utility patent for its Blood Volume Monitor Device. Thomas Sandgaard , the inventor, has assigned the patent to... Read More
Thursday January 7, 2021 0 comments
Ampio provides update on clinical trials for Ampion treatment of COVID-19
ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced an update on the launch of a new global clinical trial for intravenous treatment of COVID-19 with Ampion and provided updates... Read More
Tuesday January 5, 2021 0 comments
Ampio gets FDA feedback on proposed modifications to special protocol assessment for Ampion
ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) today announced it received guidance from the U.S Food Drug Administration regarding the impact of COVID-19 on its Phase III clinical... Read More
Wednesday December 30, 2020 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
